Detalhe da pesquisa
1.
Safety, Pharmacokinetics, and Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-Associated Hepatitis.
Am J Gastroenterol
; 119(1): 107-115, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37011138
2.
Dosing of Rifaximin Soluble Solid Dispersion Tablets in Adults With Cirrhosis: 2 Randomized, Placebo-controlled Trials.
Clin Gastroenterol Hepatol
; 21(3): 723-731.e9, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35750249
3.
Safety, pharmacokinetics and antiviral activity of ABI-H2158, a hepatitis B virus core inhibitor: A randomized, placebo-controlled phase 1 study.
J Viral Hepat
; 30(3): 209-222, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36302125
4.
Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial.
J Hepatol
; 77(3): 607-618, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35439567
5.
Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection.
J Hepatol
; 77(3): 642-652, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35460726
6.
Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection.
J Hepatol
; 77(5): 1265-1275, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35697332
7.
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH.
Hepatology
; 73(2): 625-643, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33169409
8.
Durability of sustained virological response to glecaprevir/pibrentasvir and resistance development: A long-term follow-up study.
Liver Int
; 42(6): 1278-1286, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35220658
9.
Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II study.
J Hepatol
; 73(2): 231-240, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32234329
10.
Variability and Lability of Ammonia Levels in Healthy Volunteers and Patients With Cirrhosis: Implications for Trial Design and Clinical Practice.
Am J Gastroenterol
; 115(5): 783-785, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31449156
11.
Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L-PLUS 2).
Hepatology
; 70(4): 1336-1348, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30762895
12.
Treatment Options for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing a Scheduled Procedure.
J Clin Gastroenterol
; 54(6): 503-511, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32195771
13.
Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.
Gastroenterology
; 155(3): 705-718, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29778606
14.
Efficacy and Pharmacokinetics of Glecaprevir and Pibrentasvir With Concurrent Use of Acid-Reducing Agents in Patients With Chronic HCV Infection.
Clin Gastroenterol Hepatol
; 17(3): 527-535.e6, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30012435
15.
Efficacy and safety of ruzasvir 60 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4 or 6 infection.
J Viral Hepat
; 26(6): 675-684, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30739366
16.
Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial.
Hepatology
; 67(2): 514-523, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28926120
17.
Mass screening for hepatitis B and C in Southern Upper Egypt.
BMC Public Health
; 19(1): 1326, 2019 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31640639
18.
Eliminating hepatitis C within low-income countries - The need to cure genotypes 4, 5, 6.
J Hepatol
; 68(4): 814-826, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29229584
19.
Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis.
Clin Gastroenterol Hepatol
; 16(3): 417-426, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28951228
20.
Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial.
Liver Transpl
; 24(3): 380-393, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29171941